| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 05/23/2006 | US7049424 Genes from the 20Q13 amplicon and their uses |
| 05/23/2006 | US7049423 Nucleic acids coding fuion protein; gene expression |
| 05/23/2006 | US7049422 Tumor necrosis related receptor, TR7 |
| 05/23/2006 | US7049421 Polynucleotide encoding a gene product having tricothecene resistance activity that thereby confers trichothecene resistance to transgenic plants, plant tissues, plant seeds, and plant cells; fungicides |
| 05/23/2006 | US7049420 Using gene product; polynucleotides; antitumor, anticancer agent |
| 05/23/2006 | US7049419 Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
| 05/23/2006 | US7049409 Heregulin-like factor antibodies |
| 05/23/2006 | US7049404 Polypeptide human polyadenylation binding protein 20.13 and polynucleotide encoding it |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049138 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 05/23/2006 | US7049137 KCNQ5, a novel potassium channel |
| 05/23/2006 | US7049131 Methods and deoxyribonucleic acid for the preparation of tissue factor protein |
| 05/23/2006 | US7049129 Electro-optical devices and methods for hybridization and detection |
| 05/23/2006 | US7049128 For therapy of vascular inflammation and other vascular disorders associated with platelet activation |
| 05/23/2006 | US7049126 Human serine protease |
| 05/23/2006 | US7049125 EGVIII endoglucanase and nucleic acids encoding the same |
| 05/23/2006 | US7049121 For therapy of cocaine-induced condition; cocaine hydrolysis activity |
| 05/23/2006 | US7049120 Regulation of human mrp5-like protein |
| 05/23/2006 | US7049119 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2006 | US7049118 isolated and purified protein and complimentary DNA; culturing a host cell to express the regulatory protein; biodrugs; enzyme inhibitors; anticarcinogenic, antidiabetic agents; nervous system disorders; chronic obstructive pulmonary disorder |
| 05/23/2006 | US7049116 Genetically engineered enzyme for use in the treatment of cell proliferative disorders |
| 05/23/2006 | US7049115 Genes encoding denitrification enzymes |
| 05/23/2006 | US7049114 Glucose dehydrogenase |
| 05/23/2006 | US7049112 Comprise CPRA protein (cytochrome enzyme complexes) for bioynthesis of long chain aliphatic dioic acids |
| 05/23/2006 | US7049102 Multi-gene expression profile |
| 05/23/2006 | US7049098 Detecting preferential polypeptide in sample; generate expression vector containing preferential protein, express vector, detect preferential polypeptide in sample |
| 05/23/2006 | US7049097 Antibiotics-independent vector for constant high-expression and method for gene expression using the same |
| 05/23/2006 | US7049096 Polynucleotides encoding a novel human G-protein coupled receptor splice variant HGPRBMY29sv1 |
| 05/23/2006 | US7049095 DNA encoding IL-1 receptor accessory protein |
| 05/23/2006 | US7049094 Detection of modulator of transport protein activity; obtain sample containing transport protein, incubate with potential modulator, monitor binding activity, reduction in binding indicates effective modulator |
| 05/23/2006 | US7049092 drug screening for male antifertility agents by screening for inhibitors of said lipase which would have spermatogenesis inhibiting activity |
| 05/23/2006 | US7049078 Apolipoprotein E polymorphism and treatment of alzheimer's disease |
| 05/23/2006 | US7049076 Method for assaying protein—protein interaction |
| 05/23/2006 | US7049075 Deoxyribonuclease IIβ proteins and cDNAs |
| 05/23/2006 | US7049073 Using phosphoramidite compound; biosynthesis |
| 05/23/2006 | US7049072 Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state |
| 05/23/2006 | US7049070 Detecting variation in nucleotide sequence pattern; obtain nucleotide squences, depolymerize, separate sequences, monitor mobility pattern of nucleotide sequences |
| 05/23/2006 | US7049068 Screening sample for annealed nucleotide sequences; obtain sample of nucleotide sequences, incubate with probes and transition metal comples, detect oxidation reduction reactions, detect annealed nucleotide sequences |
| 05/23/2006 | US7049066 Diagnosis and treatment of myocardial failure |
| 05/23/2006 | US7049065 Method of preparing normalized and/or subtracted cDNA |
| 05/23/2006 | US7049063 Lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. |
| 05/23/2006 | US7048931 polypeptide with prostate-specific proteins, immunogenic portions or a T cell that is specific for cells expressing such a protein |
| 05/20/2006 | CA2527167A1 Nucleic acid preparation |
| 05/18/2006 | WO2006053313A2 Elaiophylin biosynthetic gene cluster |
| 05/18/2006 | WO2006053299A2 Site-directed modification of fviii |
| 05/18/2006 | WO2006053246A2 A new sos 1 gene from halophila that confers salt tolerance |
| 05/18/2006 | WO2006052914A2 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | WO2006052912A2 Acyltransferase regulation to increase the percent of polyunsaturated fatty acids in total lipids and oils of oleaginous organisms |
| 05/18/2006 | WO2006052900A2 Targeted innate immunity |
| 05/18/2006 | WO2006052871A2 Docosahexaenoic acid producing strains of yarrowia lipolytica |
| 05/18/2006 | WO2006052870A2 High eicosapentaenoic acid producing strains of yarrowia lipolytica |
| 05/18/2006 | WO2006052824A2 A mortierella alpina glycerol-3-phosphate o-acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | WO2006052814A2 A mortierella alpina diacylglycerol acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | WO2006052807A2 A dna molecule of mortierella alpina lpaat homolog |
| 05/18/2006 | WO2006052534A2 Expansion of nk cells and therapeutic uses thereof |
| 05/18/2006 | WO2006052391A2 Heterocyclic inhibitors of ires-mediated translation and methods of use thereof |
| 05/18/2006 | WO2006051545A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 05/18/2006 | WO2006051397A2 Oligonucleotide probes |
| 05/18/2006 | WO2006050734A2 Potent lna oligonucleotides for the inhibition of hif-1a expression |
| 05/18/2006 | WO2006029161A3 Cell specific gene silencing using cell-specific promoters in vitro and in vivo |
| 05/18/2006 | WO2005108611A3 Methods and compositions for the amplification of mutations in the diagnosis of cystic fibrosis |
| 05/18/2006 | WO2005108415A8 Membrane associated molecules |
| 05/18/2006 | WO2005089268A3 Compositions and methods for optimizing cleavage of rna by rnase h |
| 05/18/2006 | WO2005067491A3 Toxin complex proteins and genes from xenorhabdus bovienii |
| 05/18/2006 | WO2005035550A3 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier |
| 05/18/2006 | WO2005019422A3 Silencing of tgf-beta receptor type ii expression by sirna |
| 05/18/2006 | WO2003106616A3 MEMBRANE-ANCHORED ß2 MICROGLOBULIN COVALENTLY LINKED TO MHC CLASS I PEPTIDE EPITOPES |
| 05/18/2006 | WO2003100082A3 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 05/18/2006 | US20060107351 Cell visual characteristic-modifying sequences |
| 05/18/2006 | US20060107350 Fatty acid elongases |
| 05/18/2006 | US20060107346 Vector construct of a nitrogen responsive promoter that directs transcription, and a second nucleic acid molecule having to be transcribed; first and second nucleic acid molecules are heterologous to each other |
| 05/18/2006 | US20060107345 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
| 05/18/2006 | US20060107344 Organ preferential genes identified by T-DNA insertional mutagenesis of rice |
| 05/18/2006 | US20060107343 Plant cells and plant bodies with modified cell growth, development and differentiation |
| 05/18/2006 | US20060107342 Expressing within the plant a cystathionine gamma -synthase encoded by a polynucleotide mutated in, or lacking, a region encoding an N-terminal portion of cystathionine gamma -synthase, region being functional in downregulating an activity of cystathionine gamma -synthase in the plant |
| 05/18/2006 | US20060107337 Elimination of endogenous porcine retrovirus |
| 05/18/2006 | US20060106208 Process and equipment for plasmid purfication |
| 05/18/2006 | US20060106207 3-phosphoglycerate dehydrogenase having a reduced feedback inhibition by L-serine; produced by deleting at least 79 amino acids at the C terminus of the wild-type serA sequence |
| 05/18/2006 | US20060106203 Immunoglobulin variable domain; tumor necrosis factor; competitve binding; pharmacokinetics; surface plasmon resonance; host cell |
| 05/18/2006 | US20060106202 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 05/18/2006 | US20060106201 Novel hemopoietin receptor protein, NR12 |
| 05/18/2006 | US20060106199 Streptavidin-binding peptide |
| 05/18/2006 | US20060106197 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 05/18/2006 | US20060105981 Therapeutic agents for treatment of solid tumors comprising an expression-inhibiting substance against Wilms' tumor gene (WT1) |
| 05/18/2006 | US20060105980 ARC186 aptamer PEG conjugate; transplant rejection; cardiovascular disorders; angioplasty; restenosis; specificity and affinity of the aptamer can be tightly controlled and allows the generation of leads; no toxicity or immunogenicity; chemical stability |
| 05/18/2006 | US20060105977 Desmoglein 4 is a novel gene involved in hair growth |
| 05/18/2006 | US20060105976 RNAi modulation of ApoB and uses thereof |
| 05/18/2006 | US20060105975 Nucleic acid conjugate comprising delivery aptamer connected to oligonucleotide; delivery aptamer may be connected directly to oligonucleotide, or may be connected indirectly to oligonucleotide, such as through a linker; oligonucleotide may be therapeutic, diagnostic or imaging oligonucleotide |
| 05/18/2006 | US20060105974 Conjugates of photosensitizers and oligonucleotides for selective photochemiotherapy |
| 05/18/2006 | US20060105973 nucleosides, phosphorothioate linkages; colloids; osteoporosis; depression; metabolic disorders such as obesity, diabetes, atherosclerosis and hyperlipidemia |
| 05/18/2006 | US20060105953 Polynucleotide encoding polypeptide which is protected from proteosomal degradation by cleavage of linking group; |
| 05/18/2006 | US20060105951 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 05/18/2006 | US20060105914 Plant wall degradative compounds and systems |
| 05/18/2006 | US20060105451 Genetically engineered P30 antigen improved antigen cocktail, and uses thereof |
| 05/18/2006 | US20060105442 Promoters and proteins from Clostridium thermocellum and uses thereof |
| 05/18/2006 | US20060105429 Nucleic acid encoding protein which comprises hormone and has higher plasma stability; maintains biological activity for prolonged period in body |
| 05/18/2006 | US20060105428 Alkaline protease |
| 05/18/2006 | US20060105427 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/18/2006 | US20060105426 mcFP encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 05/18/2006 | US20060105425 Aspergillus niger promoter for expressing genes in host cells |